SCHEMBL4069625

SCHEMBL4069625

OC(C(Cl)Cl)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18422707 0.76 CETP (0.39)
SCHEMBL3422966 0.76 CETP (0.39)
SCHEMBL18422910 0.76 CETP (0.39)
SCHEMBL1316837 0.72
Chloroform SCHEMBL5313122 0.67 ALDH1A1 (0.41)
SCHEMBL1075071 0.67 CETP (0.33)
SCHEMBL26092 0.67
SCHEMBL14817655 0.67
SCHEMBL846347 0.67
Chloroform SCHEMBL6152248 0.67 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115057913-A Preparation method of gramicidin S analogue GS-5 遵义医科大学珠海校区 2022-09-16 CN disclosed
CN-112175067-B Preparation method of teduglutide 深圳市星银医药有限公司 2022-04-15 CN disclosed
CN-111961117-B Cyclopeptide compound and application thereof 中山大学 2022-03-11 CN disclosed
CN-113651837-A Preparation method of 3,3, 3-trifluoropropanol 山东华安新材料有限公司 2021-11-16 CN disclosed
CN-112175067-A Preparation method of teduglutide 深圳市星银医药有限公司 2021-01-05 CN disclosed
CN-111732651-B Method for preparing Somalutide through continuous flow solid phase reaction 苏州金顶生物有限公司 2020-12-08 CN disclosed
CN-111961117-A Cyclopeptide compound and application thereof 中山大学 2020-11-20 CN disclosed
CN-111732651-A Method for preparing Somalutide through continuous flow solid phase reaction 苏州金顶生物有限公司 2020-10-02 CN disclosed
CN-110891593-A NORRIN-inducible expression of genes and application thereof in treating diseases 瑞特诺解决方案有限责任公司 2020-03-17 CN disclosed
CN-110072864-A TDO2 INHIBITORS 基因泰克公司 2019-07-30 CN disclosed
US-20170267725-A1 Peptidomimetics for Treating HER2-Overexpressed Cancer Board of Supervisors for the University of Louisiana System (US) 2017-09-21 US disclosed
EP-0988394-B1 COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF ONCOIMMUNIN INC (US) 2009-12-30 EP disclosed
US-7550592-B2 Hydromorphone polymorphs NORAMCO, INC. (US) 2009-06-23 US disclosed
US-20060235039-A1 Four novel forms of hydromorphone HCl identified herein as Forms B, C, D and an amorphous form; useful as analgesic agents either in combination with or as replacements for hydromorphone hydrochloride; useful as analgesic agents NORAMCO, LLC (FORMERLY KNOWN AS NORAMCO, INC.) 2006-10-19 US disclosed
JP-2004091368-A HALOGEN-CONTAINING ALCOHOL AND ITS PRODUCTION METHOD CENTRAL GLASS CO LTD 2004-03-25 JP disclosed
WO-2004020376-A1 HALOGENATED ALCOHOL AND PROCESS FOR PRODUCING THE SAME CENTRAL GLASS COMPANY, LIMITED (JP) 2004-03-11 WO disclosed
EP-0842195-A1 PEPTIDE INHIBITORS OF FIBRONECTINE ZENECA LIMITED (GB) 1998-05-20 EP disclosed
WO-1997002289-A1 PEPTIDE INHIBITORS OF FIBRONECTINE ZENECA LIMITED (GB) 1997-01-23 WO disclosed
EP-0285562-B1 SYNTHETIC RESIN CIBA-GEIGY AG (CH) 1993-04-28 EP disclosed
EP-0285562-A2 Synthetic resin CIBA-GEIGY AG (CH) 1988-10-05 EP disclosed